Premium

Investment bank Jefferies has maintained a “Hold” rating on the stock, with a target price of AUD 17.70. This suggests limited upside in the near term, as analysts weigh the company’s resilient fundamentals against elevated claims costs and macroeconomic headwinds.

Paradigm Biopharmaceuticals (ASX:PAR) closed at AUD 0.19 on 27 April 2026, down 15.56% for the session, with turnover well above average volume as investors reacted to a discounted capital raising and attaching option structure. In biotechnology, sharp single-day declines do not always reflect deterioration …

Avecho Biotechnology (ASX:AVE) entered the week trading at AUD 0.011, at the upper end of its recent day range and near the top of its 52-week range, with the stock up 10% over the past five sessions as of 27 April 2026. For a …

Shares of Harvey Norman Holdings Limited (ASX:HVN) were recently trading at $4.525, reflecting a marginal decline of 0.11% in the latest session. Despite the subdued daily movement, the stock has maintained relative stability, underpinned by solid financial performance and consistent dividend delivery.

Shares of Judo Capital Holdings Limited (ASX:JDO) were recently trading at $1.437, up 2.68% in the latest session. The upward movement reflects improved investor sentiment following the company’s trading update and supportive broker commentary.

Shares of PLS Group Limited (ASX:PLS) were recently trading at $5.945, up 3.03% in the latest session. The gain reflects renewed investor confidence, supported by a strong March 2026 quarterly update and improving lithium market conditions.

Shares of AMP Limited (ASX:AMP) were recently trading at $1.442, reflecting a marginal gain of 0.17% in the latest session. The relatively muted share price movement comes despite a constructive operational update, suggesting that investors are taking a measured view of the company’s ongoing …